Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
SUPN compared with LGND: revenue, margins and what each company keeps, and the suppliers and customers both name
SUPN
Supernus Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
LGND
Ligand Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
SUPN
Supernus Pharmaceuticals, Inc.
vs
LGND
Ligand Pharmaceuticals Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
SUPN, solid
LGND, dashed
SUPN
Supernus Pharmaceuticals, Inc.
Change
26.15
▼
−2.21%
· post 26.15
Mkt cap
$3.1B
Revenue
$356M
Q3 FY26
Revenue
$719M
FY25
LGND
Ligand Pharmaceuticals Inc
Change
306.27
▲
+2.43%
· post 308.00
Closed
Nov 6 '26
Mkt cap
$6.1B
Revenue
$79M
Q3 FY26
Revenue
$268M
FY25
vs
Compare
Closed
Nov 6 '26
SUPN
Supernus Pharmaceuticals, Inc.
vs
LGND
Ligand Pharmaceuticals Inc
26.15
▼
−2.21%
post 26.15
Price
306.27
▲
+2.43%
post 308.00
$3.1B
Mkt cap
$6.1B
Q3 FY26
$356M
Revenue
$79M
Q3 FY26
FY25
$719M
Revenue
$268M
FY25
Change
Change
SUPN
26.15
▼
−2.21%
vs
LGND
306.27
▲
+2.43%
Closed
Nov 6 '26